Atlas FDA

DEXCOM STS CONTINOUS MONITORS

FDA premarket approval P050012 · decided 2006-03-24

Approval details

PMA number
P050012
Trade name
DEXCOM STS CONTINOUS MONITORS
Generic name
Sensor, glucose, invasive
Applicant
Dexcom, Inc.
Date received
2005-03-23
Decision date
2006-03-24
Days to decision
366 days
Decision code
APWD
Product code
MDS
Advisory committee
Clinical Chemistry
Expedited review
No
Location
San Diego, CA
Statement
APPROVAL FOR THE DEXCOM STS CONTINUOUS GLUCOSE MONITORING SYSTEM. THE DEVICE IS INDICATED FOR THE FOLLOWING: 1) INDICATED FOR DETECTING TRENDS AND TRACKING PATTERNS IN ADULTS (18 AND OLDER) WITH DIABETES AND IS INTENDED FOR USE BY PATIENTS AT HOME AND IN HEALTH CARE FACILITIES. THE DEVICE IS FOR PRESCRIPTION USE. 2) INDICATED FOR USE AS AN ADJUNCTIVE DEVICE TO COMPLEMENT, NOT REPLACE, INFORMATION OBTAINED FROM STANDARD HOME GLUCOSE MONITORING DEVICES. 3) AIDS IN THE DETECTION OF EPISODES OF HYPE

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Stelo Glucose Biosensor System (K260935)Dexcom, Inc.2026-06-12
Dexcom G7 Continuous Glucose Monitoring System;Dexcom G7 15 Day Continuous Glucose Monitoring System (K261402)Dexcom, Inc.2026-06-08
Stelo Glucose Biosensor System (K261359)Dexcom, Inc.2026-05-21
Dexcom G7 Continuous Glucose Monitoring (CGM) System; Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System (K253737)Dexcom, Inc.2026-02-03
Dexcom G7 Continuous Glucose Monitoring (CGM) System, Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System (K253710)Dexcom, Inc.2025-12-17
Dexcom Smart Basal (K252818)Dexcom, Inc.2025-11-18
Dexcom G7 15 Day Continuous Glucose Monitoring System (K243214)Dexcom, Inc.2025-04-09
Dexcom G7 Continuous Glucose Monitoring System (K240902)Dexcom, Inc.2024-04-23